Acura Pharmaceuticals (ACUR)

0.62  -0.16 (-20.51%)

After market: 0.61 -0.01 (-1.61%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Acura Pharmaceuticals

NASDAQ:ACUR (2/22/2017, 7:10:00 PM)

After market: 0.61 -0.01 (-1.61%)

0.62

-0.16 (-20.51%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap7.37M
Shares
PEN/A
Fwd PEN/A
Dividend Yield0%
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

ACUR Daily chart

Company Profile

Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.

Company Info

Acura Pharmaceuticals

616 N. NORTH COURT SUITE 120

PALATINE IL 60067

P: 847-705-7709

CEO: Robert B. Jones

ACUR News

News Image2 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date...

News Image2 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals Provides Development Update on LTX-03

PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and...

News Image2 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research,...

News Image3 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
News Image3 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date

News Image3 years ago - Acura Pharmaceuticals, Inc.Acura Pharmaceuticals Announces Conversion of Debt

ACUR Twits

Here you can normally see the latest stock twits on ACUR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example